2005
DOI: 10.1016/j.transproceed.2005.03.126
|View full text |Cite
|
Sign up to set email alerts
|

Circulating Endothelial Cells in Renal Transplant Recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…Consistent with this, data from FISH analysis 38 in humans suggest that in patients that underwent prior BM or kidney transplantation, ECs can be replaced by the recipient's cells. 39,40 This special allogenic situation is also associated with increased numbers of circulating mature ECs, [41][42][43] which might become integrated into the renal microvasculature.…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with this, data from FISH analysis 38 in humans suggest that in patients that underwent prior BM or kidney transplantation, ECs can be replaced by the recipient's cells. 39,40 This special allogenic situation is also associated with increased numbers of circulating mature ECs, [41][42][43] which might become integrated into the renal microvasculature.…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, several methods and markers for endothelial dysfunction have been studied in kidney allograft recipients due to higher cardiovascular mortality in these patients in comparison with healthy subjects [1][2][3][4][5][6][7][8][9][10]. While uremic status and related factors such as calcium-phosphorus balance, hypervolemia, anemia, oxidative stress, hyperparathyroidism, inflammation and hyperhomocysteinemia resolve after transplantation, we do not know clearly whether kidney transplantation improves long-term changes of uremia in the cardiovascular system (left ventricular structural abnormality, coronary calcification, arterial changes induced by arteriosclerosis).…”
Section: Discussionmentioning
confidence: 99%
“…In recent studies, there has been an increased interest in the evaluation of endothelial dysfunction as an early abnormality in atherosclerosis not only in patients with end stage renal disease but also in RTx recipients [2][3][4][5][6][7]. Various endothelial dysfunction markers and methods including flowmediated dilatation (FMD), high-sensitive C-reactive protein (CRP), fetuin-A, visfatin, homocysteine, several cytokines, circulating endothelial cells and progenitor cells, plasma soluble von Willebrand factor antigen and adhesion molecules have been defined [2][3][4][5][6][7][8][9]. In recent years, thrombomodulin (TM), which is a transmembrane cofactor of the endothelial cells, and endothelial protein C receptor (EPCR), which plays an important role in activation of protein C in the coagulation cascade, have been described as new markers of endothelial dysfunction, and the soluble forms of both markers increase in situations of endothelial damage such as vasculitis, systemic lupus erythematosus (SLE) and sepsis [10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Woywodt et al demonstrated that patients with acute vascular rejection had the highest cell numbers compared with other patients [61]. Mohamed et al found that the cells seemed to be derived from the graft itself [81]. Therefore, kidney transplantation may have a remarkable effect on endothelial damage.…”
Section: Clinical Value Of Circulating Endothelial Cells In Transpmentioning
confidence: 99%